In this respect, higher PAI-1 levels coincide with a decreased mean low-density lipoprotein (LDL) size and higher amounts of small-dense LDL lipoprotein fraction, which importantly contribute to the atherogenic lipid profile and increased cardiovascular risk in obesity [76]. The gene discussed is SERPINE1; the disease is obesity due to melanocortin 4 receptor deficiency.